Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy

Table 1

Patient characteristics.

Patient	Age	Sex	Race	Overall comorbidity severity	Moderate and severe comorbidities	KPS	Immune dysfunction
1	83	M	W	Mild		80
2	82	F	W	Mild		80	CLL
3	70	M	W	Moderate	Respiratory	80
4	59	M	W	Moderate	Cardiovascular (congestive heart failure, arrhythmia)	70	Heart transplant
5	78	M	W	Moderate	Obesity	80
6	85	M	W	Moderate	Cardiovascular (arrhythmia)	80
7	47	M	W	Severe	Immunologic (AIDS)	70	AIDS
8	78	M	W	Moderate	Malignancy (leukemia)	70	CLL
9	75	M	W	Severe	Endocrine (diabetes), respiratory, malignancy (leukemia)	90	CLL
10	77	M	W	Mild		80
11	90	M	W	Severe	Malignancy (solid tumor)	50
12	86	M	W	Severe	Malignancy (solid tumor)	60

Demographic, comorbidity, and immune system dysfunction for each of the patients (𝑛=12) studied.
KPS: Karnofsky performance status, M: male, F: female, W: white, CLL: chronic lymphocytic leukemia, and AIDS: acquired immunodeficiency syndrome.